Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (440)	12/8/2003 11:13:53 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

GNTA Started with an upgap that lasted only 5 minutes and then had a persistent down trading, albeit volume remains low.<g> The nearest support is at 10.12 and resistance at 11.85 On September 10,the day of its recent H at 17.65, most of the heavy volume of 16.273M was to the downside and it ended the day not far from its L of 14.76 <g> Today it announced results combining its Genasense with chemotherapy for patients older than 60 with AML.It said results showed Genasense was "safe" and it seemed to enhance the activity of the chemotherapy. siliconinvestor.com Bernard